NATIXIS - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$112,563
+1671.5%
15,989
+1437.4%
0.00%
Q1 2023$6,354
-4.4%
1,0400.0%0.00%
Q4 2022$6,646
-99.7%
1,040
-99.3%
0.00%
-100.0%
Q1 2022$2,382,000
+721.4%
143,040
+1185.1%
0.01%
+700.0%
Q2 2021$290,00011,1310.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders